Ranbaxy withdraws anti-infectives from prequalified products list
see also: WHO Media Centre: http://www.who.int/entity/mediacentre/news/notes/2005/n
WHO News Release WHO/87, WHO Geneva.
WHO, Geneva.
WHO Geneva.
WHO Geneva. Department of Essential Drugs and Medicines Policy; Department of HIV/AIDS
New edition of WHO prequalification list to include four new anti-AIDS medicines; assessment reports to be made public in coming days
From The New York Times, 16 June 2004
By Lawrence K. Alyman & Donald G. McNeil Jr.
From The New York Times, Thursday, March 21, 2002
Inclusion of products is setback for pharmaceutical giants.
From The New York Times Thursday, March 20, 2002
By Donald G. McNeil Jr.
From The Wall Street Journal, 20 March 2002
By Rachel Zimmerman
WHO Member States are increasingly stepping up to increase human resources and manufacturing capacities for local production.
The presentations of the 2024 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 2 to 6 December 2024 at UN City, Copenhagen, Denmark are now available at:
UPDATE - Request for Proposals (RFP) Withdrawn for Internal Reasons
for more information click here
WHO Prequalification is inviting you to review the draft working document on Technical Specifications Series for submission to WHO Prequalification – Medical Device Assessment Screenin
Ensuring access to quality-assured, safe and effective therapies is a core part of WHO’s mission.
The WHO Immunization Devices and Equipment Prequalification Team is seeking to enter into a contractual agreement with a successful bidder to implement the following work packages: